...
首页> 外文期刊>International Journal of Environmental Research and Public Health >Horizon 2020 Priorities in Clinical Mental Health Research: Results of a Consensus-Based ROAMER Expert Survey
【24h】

Horizon 2020 Priorities in Clinical Mental Health Research: Results of a Consensus-Based ROAMER Expert Survey

机译:Horizo​​n 2020临床精神健康研究的重点:基于共识的ROAMER专家调查的结果

获取原文
           

摘要

Within the ROAMER project, which aims to provide a Roadmap for Mental Health Research in Europe, a two-stage Delphi survey among 86 European experts was conducted in order to identify research priorities in clinical mental health research. Expert consensus existed with regard to the importance of three challenges in the field of clinical mental health research: (1) the development of new, safe and effective interventions for mental disorders; (2) understanding the mechanisms of disease in order to be able to develop such new interventions; and (3) defining outcomes (an improved set of outcomes, including alternative outcomes) to use for clinical mental health research evaluation. Proposed actions involved increasing the utilization of tailored approaches (personalized medicine), developing blended eHealth/mHealth decision aids/guidance tools that help the clinician to choose between various treatment modalities, developing specific treatments in order to better target comorbidity and (further) development of biological, psychological and psychopharmacological interventions. The experts indicated that addressing these priorities will result in increased efficacy and impact across Europe; with a high probability of success, given that Europe has important strengths, such as skilled academics and a long research history. Finally, the experts stressed the importance of creating funding and coordinated networking as essential action needed in order to target the variety of challenges in clinical mental health research.
机译:在旨在提供欧洲心理健康研究路线图的ROAMER项目中,对86名欧洲专家进行了为期两阶段的德尔菲调查,以确定临床心理健康研究的优先领域。关于临床心理健康研究领域的三个挑战的重要性,已经达成专家共识:(1)开发针对精神障碍的新的,安全有效的干预措施; (2)了解疾病的机制,以便能够开发出这种新的干预措施; (3)定义用于临床心理健康研究评估的结果(一组改进的结果,包括其他结果)。拟议的行动包括增加对量身定制的方法(个性化药物)的利用,开发混合的eHealth / mHealth决策辅助工具/指导工具,以帮助临床医生在各种治疗方式之间进行选择,开发特定的治疗方法,以更好地针对合并症和(进一步)发展生物,心理和心理药物干预。专家们指出,解决这些优先事项将提高整个欧洲的效力和影响;欧洲拥有重要的优势,例如技术娴熟的学者和悠久的研究历史,因此很有可能获得成功。最后,专家们强调了建立资金和协调网络的重要性,这是针对临床心理健康研究中各种挑战所必需的基本行动。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号